PPT-EU Trade policy & Access to Medicines

Stops AIDS National Gathering 1st November 2014 Aliénor Devali ère Health Action International HAI Europe This document arises from HAI Europes Operating Grant 2014 which has received funding from the . Zimbabwe. Presentation t. o Civil Society meeting. Harare. 21 January. 2014. Patents make medicines unaffordable!. Patents create monopolies and dependencies. Beneficial for R&D companies (in rich countries). Dennis Ross-Degnan, ScD. Harvard Medical School and Harvard Pilgrim Health Care . WHO Collaborating Center in Pharmaceutical Policy. Boston, USA. Overview. Research methods. Cross-cutting research areas. Willem Scholten, PharmD, MPA. Team Leader, Access to Controlled Medicines,. World Health Organization, Geneva, Switzerland. TECHNICAL BRIEFING SEMINAR . Geneva, 29 October – 2 November 2012. Overview. –. lessons from HIV. EPIP, 5 September 2017, Bordeaux. . Ellen ‘t Hoen, LLM. University Medical Centre Groningen, Global Health Unit. @. ellenthoen. www.medicineslawandpolicy.org. Brief history. Willem Scholten, PharmD, MPA. Team Leader, Access to Controlled Medicines,. World Health Organization, Geneva, Switzerland. TECHNICAL BRIEFING SEMINAR . Geneva, 29 October – 2 November 2012. Overview. Gilles Forte. Policy. , Access and Use Team. Department for Essential . Medicines and Health Products. World Health Assembly Resolution 67.22 . Access . to essential medicines. Recognize . the importance of effective national medicines policies, and their . IPC Meeting . 4 to 6 . June. 2014. Essential Medicines and Health Products Department (EMP) . . . October. 2013. . Office of the . Willem Scholten, PharmD, MPA. Team Leader, Access to Controlled Medicines,. World Health Organization, Geneva, Switzerland. TECHNICAL BRIEFING SEMINAR . Geneva, 29 October – 2 November 2012. Overview. Dr Cécile . Macé. . WHO EMP , Mr Arne-Petter . Sanne. WHO MND, . Mr . Ajuebor. Onyema WHO MND. NCD Programme Managers Seminar. 4 June 2014. Access to NCD essential medicines . on the global agenda. IPC Meeting . 4 to 6 . June. 2014. Essential Medicines and Health Products Department (EMP) . . . October. 2013. . Office of the . Case Management. George Jagoe . EVP, Access & Product Management, MMV. . . The access team at MMV is heavily focused on the needs of control today. 4. Achieving patient impact means addressing many hurdles to access. Globalising Asia: Health Law, Governance, and Policy – Issues, Approaches, and Gaps!. Bangkok 16-18 April, 2012. Scheme. Gaps in policy direction. Understanding competition law/policy (CL/P). CL/P interface with health sector and related issues. TRADING AWAY HEALTH: THE TRANS-PACIFIC PARTNERSHIP AGREEMENT (TPP) MSF Access Campaign Médecins Sans Frontières, Rue de Lausanne 78, CP 116, CH-1211 Geneva 21, Switzerland Tel: + 41 (0) 22 849 84 Basic enquiry answering. September . 2016. Session aims. Increase awareness of the Medicines Information (MI) services. UK. Wales. Increase awareness of the questions to ask an enquirer. Have practical experience using some resources which will be...